APA (7th ed.) Citation

Panou, T., Gouveri, E., Popovic, D. S., Papazoglou, D., & Papanas, N. (2025). The Therapeutic Potential of Dipeptidyl Peptidase 4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Diabetic Peripheral Neuropathy. Diabetes Therapy, 16(6), 1077. https://doi.org/10.1007/s13300-025-01712-z

Chicago Style (17th ed.) Citation

Panou, Theodoros, Evanthia Gouveri, Djordje S. Popovic, Dimitrios Papazoglou, and Nikolaos Papanas. "The Therapeutic Potential of Dipeptidyl Peptidase 4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Diabetic Peripheral Neuropathy." Diabetes Therapy 16, no. 6 (2025): 1077. https://doi.org/10.1007/s13300-025-01712-z.

MLA (9th ed.) Citation

Panou, Theodoros, et al. "The Therapeutic Potential of Dipeptidyl Peptidase 4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Diabetic Peripheral Neuropathy." Diabetes Therapy, vol. 16, no. 6, 2025, p. 1077, https://doi.org/10.1007/s13300-025-01712-z.